All In Biotech

Free tool

FAERS Monitor: Pegasys

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 103964 or its brand name (Pegasys, Peginterferon Alfa-2a). Reports on generic versions are filed under their own applications.

Reports

53,802

Serious

22,928

43% of reports

Hospitalization

9,508

Death reported

1,801

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue9,266
  • nausea7,167
  • anaemia6,637
  • rash4,877
  • headache4,456
  • white blood cell count decreased4,232
  • pruritus4,227
  • pyrexia3,478
  • diarrhoea3,388
  • vomiting3,338
  • asthenia3,152
  • insomnia3,079
  • dyspnoea3,052
  • decreased appetite2,920
  • influenza like illness2,741

Reports by year received

View as table
YearReports
2004473
20051,118
2006661
2007655
2008786
2009971
20101,192
20111,492
201213,773
20138,523
20143,095
201517,300
2016869
2017546
2018386
2019326
2020349
2021249
2022301
2023194
2024182
2025213
2026144

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,000,357 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
white blood cell count decreasedSignal4,23215.815.456,828
anaemiaSignal6,63714.113.778,401
influenza like illnessSignal2,74113.412.930,601
decreased appetiteSignal2,9205.04.89,226
fatigueSignal9,2664.74.627,660
insomniaSignal3,0794.64.48,565
rashSignal4,8774.44.312,991
pruritusSignal4,2274.34.210,929
pyrexiaSignal3,4784.03.87,740
nauseaSignal7,1673.63.513,605
astheniaSignal3,1523.33.25,089
headacheSignal4,4562.82.75,240
vomitingSignal3,3382.82.73,886
dyspnoeaSignal3,0522.12.01,829
diarrhoeaSignal3,3882.12.01,888

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.